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Intracellular Ca2+ signals provide astrocytes with a speciﬁc form of excitability that enables them to
regulate synaptic transmission. In this study, we demonstrate that NAADP-AM, a membrane-perme-
ant analogue of the new second messenger nicotinic acid-adenine dinucleotide phosphate (NAADP),
mobilizes Ca2+ in astrocytes and that the response is blocked by Ned-19, an antagonist of NAADP sig-
nalling. We also show that NAADP receptors are expressed in lysosome-related acidic vesicles. Phar-
macological disruption of either NAADP or lysosomal signalling reduced Ca2+ responses induced by
ATP and endothelin-1, but not by bradykinin. Furthermore, ATP increased endogenous NAADP lev-
els. Overall, our data provide evidence for NAADP being an intracellular messenger for agonist-med-
iated calcium signalling in astrocytes.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
After several years of intense research, classical paradigms on
brain function have been challenged by data that demonstrate an
active and key role for glial cells [1,2]. Based on Ca2+ signals rather
than action potentials, astrocytes are excitable cells that assimilate
information from different inputs and send instructive chemical
signals to neighbouring cells. In this concept of an astrocyte-
neuron network (or tripartite synapse), astrocytes sense neuronal
activity as they express a wide range of functional neurotransmit-
ter receptors capable of inducing intracellular Ca2+ increases. In
turn, astrocytic Ca2+ increases trigger the release of many chemical
transmitters [3], such as ATP, that signal back to neurons, modulat-
ing their excitability, or to astrocytes, reinforcing the Ca2+ wave
and allowing transfer of information between them. Interestingly,
although receptor-mediated Ca2+ signals in astrocytes mainly de-chemical Societies. Published by E
ycyl-l-phenylalanine 2-naph-
nicotinic acid-adenine dinu-
ciències and Departament de
ma de Barcelona, Ediﬁci M,
rcelona, Catalonia, Spain. Fax:
sgrau).pend on stimulation of phospholipase C, inositol 1,4,5-triphos-
phate (IP3) production, and Ca2+ release from the endoplasmic
reticulum, they differ in magnitude and spatial- and temporal
characteristics, which indicates that they are not equally capable
of stimulating gliotransmitter release.
NAADP is the most recently discovered and most potent Ca2+
mobilizing second messenger [4,5] and has been shown to control
cellular events such as insulin release from pancreatic b cells [6]
or fertilization [7]. The main features of NAADP are its ability to
mobilize Ca2+ from lysosome-related acidic organelles and its
bell-shaped concentration-effect curve [4,6,8]. NAADP is also con-
sidered as a Ca2+ trigger signal in many cell systems. The molecular
identity of NAADP receptors in mammals is still unresolved,
although two-pore channels (TPC) have been demonstrated to be
endogenous NAADP receptors in sea urchins and to act as NAADP-
activating Ca2+ channels when they are overexpressed in particular
mammalian cell lines [9,10]. It has also been suggested that tran-
sient receptor potential-mucolipin 1 channel (TRP-ML1), TRPM-2
and ryanodine receptors act as a NAADP-sensitive channels [10].
Widespread distribution of NAADP binding sites in the brain
[11] and glutamate-induced NAADP increases in whole-brain tis-
sue [12] support a role for this second messenger in the brain.
But to date, there is no evidence for NAADP as an intracellular sec-
ond messenger in astrocytes.lsevier B.V. All rights reserved.
Fig. 1. The NAADP receptor antagonist Ned-19 colocalizes with acidic vesicles. Panels (A) and (B) are micrographs showing vital ﬂuorescence staining of cortical astrocytes
with 500 nM LysoTracker Red and 100 lMNed-19, respectively; panel (C) shows the composite image. Colocalization of green and red pixels was quantiﬁed with ImageJ, and
is shown in panel D, with the hottest colours indicating highest degrees of colocalization. Panel (E) shows the correlation plot of images shown in (A) and (B).
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2.1. Materials
[32P]Nicotinamide adenine dinucleotide ([32P]NAD) (800 Ci/
mmol) was purchased from Perkin–Elmer; lysotracker red, penicil-
lin and streptomycin from Invitrogen, and endothelin-1 (human,
porcine), baﬁlomycin A1 and 2-aminoethoxydiphenylborane (2-
APB) from Tocris. Ned-19 and NAADP-AM were synthesized in
house. All other compounds were from Sigma.2.2. Tissue culture
Primary cultures of cortical astrocytes were prepared from 1-
day-old Sprague–Dawley rats following the protocol described
previously [13]. Cells were plated into 35-mm dishes containing
a coverslip at a density of 0.2  106 viable cells/ml in DMEM sup-
plemented with 10% fetal bovine serum (FBS), 50 units/ml penicil-
lin and 50 lg/ml streptomycin. The cultures were incubated at
37 C in a humidiﬁed atmosphere of 5% CO2/95% air and used at
7–20 days in vitro. Additionally, secondary cultures of cortical
astrocytes were made by seeding cells in ﬂasks. When these cells
reached conﬂuence, microglia and oligodendrocytes were removedby mechanically shaking and astrocytes were seeded onto
coverslips.
2.3. Ca2+ imaging
Astrocytes were incubated with fura-2/AM at 4 lM in Krebs
buffer with the following composition (in mM): 119 NaCl, 4.75
KCl, 5 NaHCO3, 1.2 MgSO4, 1.18 KH2PO4, 20 Hepes, 1.3 CaCl2 and
5 glucose at pH 7.4. After 1 h, cells were washed and coverslips
mounted in a static chamber on an inverted Nikon TE2000U micro-
scope, and Ca2+ imaging performed as previously described [14].
Cells were incubated with antagonists for 20 min before stimula-
tion. Cytosolic Ca2+ concentration is given as the ratio of ﬂuores-
cence obtained exciting cells at 340 and 380 nm (F340:F380
ratio). 10–20 cells from at least three independent cultures were
analysed. Data are expressed as mean ± SEM.
2.4. Immunohistochemistry and confocal microscope
Cells cultured on glass coverslips were loaded with 100 lM
Ned-19 for 1 h at 37 C and during the last 10 min 500 nM lysotrac-
ker red was added. Coverslips were mounted in a static chamber
on a LSM 510 Meta confocal microscope (Zeiss) using a 40 oil
immersion lens. Lysotracker red ﬂuorescence was visualized at
Fig. 2. NAADP-AM, a cell-permeant analogue of NAADP, induces Ca2+ responses. Cells were incubated with different concentrations of NAADP-AM, and Ca2+ responses were
recorded. Cells were also pre-treated with 100 lM Ned-19 or 50 lM GPN and then challenged with 100 nM NAADP-AM. Representative traces are shown in (A and C) and
means of the increases of the Ca2+ concentration observed for each NAADP-AM concentration were calculated (B). Number of experiments analysed is indicated in
parentheses, except for pre-treatment with Ned-19 and GPN, in which 3 and 6 experiments were performed, respectively.
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a 590 nm long-pass ﬁlter. Ned-19 ﬂuorescence was monitored
with excitation at 355 nm (UV, argon laser) and emission collected
with a band-pass ﬁlter of 415 ± 30 nm. Image analysis was done
with ImageJ 1.43r (Wayne Rasband, NIH), using Image CorrelationJ
plugin (www.gcsca.net/IJ/ImageCorrelationJ.html).
2.5. [32P]NAADP synthesis and NAADP radiobinding assay
[32P] NAADP was synthesized in a two-step reaction as
described previously [15]. To determine endogenous NAADP levels,
we used a radioreceptor binding assay extensively described by us
[15]. In brief, cells cultured in 60-mm dishes were stimulated with
ATP or vehicle and NAADP content of samples was quantiﬁed using
a competitive binding curve made with known concentrations of
NAADP. Data were normalized to calculate the fold increases over
basal NAADP levels.3. Results
3.1. NAADP is an intracellular second messenger in astrocytes
To study whether NAADP is an endogenous molecule in astro-
cytes, we ﬁrst determined intracellular NAADP levels. Our data
showed that at rest conditions NAADP was present at very low
concentrations, 5.09 ± 0.93 pmol/mg protein (n = 20). These results
are in agreement with published results of resting NAADP levels in
different tissues that range from 0.1 to 48 pmol/mg protein and
particularly with resting NAADP levels detected in whole-brain cell
suspensions (8.3 pmol/mg protein) [12].
We also investigated the presence of NAADP receptors in astro-
cytes. As their nature is not completely and unequivocally resolved
in mammalian cells and the presence of multiple binding sites for
NAADP has been suggested in the brain [11], we considered that
Ned-19, a ﬂuorescent highly selective NAADP receptor antagonist[16], was the best tool for such studies. Fig. 1 shows that Ned-19
binding sites, presumably the NAADP receptors, are present in in-
tact astrocytes with a punctate distribution and with a very high
degree of colocalization with labelling of acidic organelles with
lysotracker (correlation coefﬁcient of 0.62). It is worth noting that
not all acidic vesicles stained with lysotracker express NAADP
receptors, stressing the heterogeneity of these organelles. Con-
versely, a very small percentage of the punctate staining of NAADP
receptors did not colocalize with lysotracker, in agreement with
results suggesting that the putative NAADP TPC1 partly localizes
in endosomes [10]. On the other hand, lack of complete overlap
demonstrate that the colocalization is not an artefact of light bleed
from one channel to the other.
We then investigated whether increases in the NAADP concen-
tration induced Ca2+ responses by adding NAADP-AM, a cell per-
meable acetoxymethyl ester of NAADP, to astrocytes loaded with
fura-2. NAADP-AM is a less invasive tool than micro-injection of
NAADP or caged-NAADP and it has been shown to be effective in
numerous mammalian cell types [17]. The addition of 50 nM or
100 nM NAADP-AM produced complex Ca2+ responses with a
prominent oscillatory component (Fig. 2A). Consistent with reports
in other cell types [4,6], higher NAADP-AM concentrations induced
smaller responses, generating a ‘‘bell-shaped’’ concentra-
tion-response curve (Fig. 2B). NAADP-AM-elicited Ca2+ responses
were detected from 2 to 20 min after addition of NAADP-AM and
were abolished by pre-incubation of cells with Ned-19 (Fig. 2C),
which can be considered diagnostic for NAADP responses. Con-
versely, the lysosomal disruptor compound glycyl-l-phenylalanine
2-naphthylamide (GPN) inhibited most NAADP-AM responses (no
cells responded to NAADP-AM in ﬁve experiments and 38% of cells
responded in one experiment) (Fig. 2C) demonstrating that intra-
cellular NAADP acts on speciﬁc receptors mainly localized in lyo-
some-related Ca2+ stores. On the other hand, extracellular
addition of NAADP also induced intracellular Ca2+ increases at high
concentrations as previously reported [18,19]. Responses were het-
erogeneous. For example, some astrocytic cultures did not respond
Fig. 3. NAADP and acidic organelles mediate ATP and endothelin-1 but not bradykinin-induced Ca2+ responses. Cells were challenged with agonists in the absence or in the
presence of 100 lM Ned-19, 50 lM GPN or 2 lM baﬁlomycin A1 (Baf A1), and Ca2+ responses were induced by 100 lM ATP (A), 10 nM endothelin (ET-1) (B) or 1 lM
bradykinin (BK) (C). Representative traces are shown on the left side of the ﬁgure. Middle panels show the means of the maximum ratio increase over basal Ca2+
concentrations as percentage of its respective control (ratio increase over basal Ca2+ concentrations induced by the agonist). Right panels show means of plateau responses
(increase of Ca2+ concentrations at 3 min over basal Ca2+ concentrations) as percentage of their respective peak responses (the initial increase over basal Ca2+ concentrations).
The number of experiments performed is indicated in parentheses. Statistics: ⁄⁄⁄P < 0.001, two-tailed t test.
Fig. 4. Ca2+ responses induced by ATP, endothelin-1 and bradykinin in the presence of EGTA. Cells were stimulated with 100 lM ATP, 10 nM endothelin (ET-1) or 1 lM
bradykinin (BK) in the presence of EGTA, a calcium chelator, to inhibit extracellular Ca2+ entry. Responses are reduced and above all, more transient.
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Ca2+ responses, and in other cultures, 66% of cells exhibited slowand high Ca2+ increases (Fig. S1A and B). Moreover, Ca2+ responses
induced by extracellular NAADP were not inhibited by Ned-19 in
Fig. 5. ATP, endothelin-1 and bradykinin release Ca2+ from the endoplasmic reticulum. Cells were challenged with agonists in the absence or in the presence of an antagonist
of IP3 receptors (100 lM 2-APB) or an antagonist of cADPR signalling (100 lM 8-Br-cADPR). Panels (A), (B) and (C) show Ca2+ responses induced by 100 lM ATP, 10 nM
endothelin (ET-1) and 1 lM bradykinin (BK), respectively. Representative traces are shown on the left side of the ﬁgure. Middle panels show the means of the maximum ratio
increase over basal Ca2+ concentrations as percentage of its respective control (ratio increase over basal Ca2+ concentrations induced by the agonist). Right panels showmeans
of plateau responses (increase of Ca2+ concentrations at 3 min over basal Ca2+ concentrations) as percentage of their respective peak responses (the initial increase over basal
Ca2+ concentrations). The number of experiments performed is indicated in parentheses. Statistics: ⁄P < 0.05 and ⁄⁄⁄P < 0.001, two-tailed t test.
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cellular NAADP act on different molecular targets in astrocytes.
Taken together, these results suggest that intracellular NAADP
is an endogenous molecule in astrocytes able to induce Ca2+ release
by the activation of receptors present mainly in acidic lysosome-
related vesicles.
3.2. NAADP and acidic organelles mediate agonist-induced Ca2+
responses
We next investigated whether the NAADP signalling pathway
could be activated by extracellular stimuli in astrocytes. In partic-
ular, we analysed the Ca2+ responses elicited by ATP, endothelin-1
and bradykinin, agonists traditionally linked to phospholipase C
activation and IP3-mediated Ca2+ release from the endoplasmic
reticulum. Endothelin-1, however, has also been reported to in-
crease NAADP levels in smooth muscle [20].The addition of 100 lM ATP, 10 nM endothelin-1 or 1 lM bra-
dykinin to astrocytes elicited Ca2+ responses characterized by an
initial peak followed by a plateau phase (Fig. 3). The latter was
more sustained if induced by endothelin-1, and in all cases it
was sensitive to extracellular Ca2+ (Fig. 4) [21,22]. To determine
the participation of NAADP signalling, we ﬁrst pre-treated the cells
with 100 lM Ned-19 to block the NAADP receptor. As shown in
Fig. 3A and Fig. 3B, Ned-19 reduced the initial peak of the Ca2+
responses induced by ATP and endothelin-1, but no effect was ob-
served on the increases elicited by bradykinin (Fig. 3C). Similarly,
osmotic lysis of the lysosome-related organelles with 50 lM GPN
and Ca2+ depletion of acidic vesicles with 2 lM baﬁlomycin A1
inhibited the peak phase of ATP and endothelin-1, but not bradyki-
nin-induced, Ca2+ responses (Fig. 3A, 3B and 3C).
Reduction of the magnitude of ATP and endothelin-1-induced
Ca2+ responses by Ned-19 was similar to that achieved by blocking
the IP3-mediated Ca2+ mobilization with 100 lM 2-APB, although
Fig. 6. ATP increases intracellular NAADP levels. 32P-NAADP was used in a
competitive assay to determine the endogenous NAADP levels at rest conditions
(dotted line) and upon stimulation with 100 lM ATP (solid line). Values are
means ± SEM (n = 8) normalized to the absolute level of NAADP at time zero of each
experiment.
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(Fig. 5). This and the results with EGTA plotted in Fig. 4 suggest the
involvement of three signalling pathways in the early phases of
ATP and endothelin Ca2+ responses, which in turn, would be ampli-
ﬁed by Ca2+-induced Ca2+ release and capacitative Ca2+ entry
[21,22]. On the contrary, 100 lM 8-Br-cADPR, an antagonist of
the second messenger cADPR, had no statistically signiﬁcant effect
on the responses of ATP and endothelin-1 (Fig. 5A and B) but partly
inhibited bradykinin-induced Ca2+ increases (Fig. 5C).3.3. ATP increases NAADP levels
Our results constitute the ﬁrst report linking activation of puri-
nergic receptors and Ca2+ release from acidic organelles in mam-
malian cells. In order to further support our data we determined
intracellular NAADP levels after stimulation with ATP. We used a
sensitive radioreceptor assay with a very high degree of speciﬁcity
and that excludes any interference of the added ATP [6,15]. Fig. 6
shows that 100 lM ATP stimulated the production of NAADP over
time in astrocytes, whereas no increases were detected if Krebs
buffer was added (control). The ATP-mediated NAADP increase
was fast and transient. These data demonstrate that NAADP is in-
volved in the early phase of ATP-induced Ca2+ responses.4. Discussion
In this study we provide direct evidence that NAADP is a true
intracellular second messenger in astrocytes. The low NAADP-AM
concentrations needed to elicit a response, the bell-shaped dose-
effect curve, together with the low intracellular NAADP levels
and their fast and transient increase in response to purinergic stim-
ulation, agree with the NAADP signalling characteristics described
in other cell types [4,5,10]. Interestingly, we also showed localiza-
tion of the NAADP receptors in lysosome-related organelles and
found that GPN, a disruptor of lysosome-related stores, inhibited
most NAADP-AM-induced Ca2+ responses, suggesting that NAADP
releases Ca2+ from lysosome-related acidic vesicles.
On the other hand, in our astrocytic cultures extracellular addi-
tion of NAADP did not always elicit Ca2+ responses, even at 1 mM.
Responsive astrocytes did not show a bell-shaped dose-effect
curve, and Ca2+ increases were not inhibited by the antagonist of
NAADP receptors Ned-19. Ca2+ increases after extracellularaddition of NAADP to astrocytes have been reported previously
[18,19], although in these studies Ca2+ responses were shown at
10 lM NAADP. In both reports, NAADP-elicited responses were
heterogeneous and mediated by multiple and different signalling
mechanisms. Moreover, Heidemann et al. [18] also showed that
extracellular NADP and NAAD elicited Ca2+ responses, and Singa-
ravelu and Deitmer [19] questioned NAADP internalization in
astrocytes. Taken together all the data demonstrate that extra-
and intracellular NAADP act on different molecular targets in glial
cells.
Importantly, we are able to link intracellular NAADP signalling
to neurotransmitter-evoked Ca2+ signals in astrocytes and to show
an agonist speciﬁc proﬁle in Ca2+ mobilization. The coupling of
endothelin-1 receptors to NAADP signalling has been previously
described in smooth muscle cells [20]. Now we report, for the ﬁrst
time, that purinergic receptors traditionally linked to phospholi-
pase C also mediate NAADP-induced Ca2+ mobilization. Our con-
clusions are based on pharmacological experiments, as well as on
data obtained from a radioreceptor assay. ATP-induced NAADP
synthesis is large, rapid, and transient, in agreement with our data
showing a reduction of the initial peak phase of ATP-induced-Ca2+
responses caused by Ned-19, GPN and baﬁlomycin A1. This sug-
gests that NAADP-mediated Ca2+ release is an initial event that
triggers further Ca2+-induced Ca2+ responses in astrocytes, again
a characteristic of this signalling pathway in other cell types [5].
These ﬁndings do not exclude other Ca2+ signalling pathways at
the early phase of ATP responses, and in fact our data also point
to the participation of IP3-mediated Ca2+ release and extracellular
Ca2+ entry. In agreement, channel chatter between receptors situ-
ated in different intracellular Ca2+ stores has been previously sug-
gested [10].
It is worth noting that a previous report failed to detect in-
creases in NAADP levels in response to ATP in whole brain cell sus-
pensions [12], probably due to the presence of cell types other than
cortical astrocytes, in which ATP might not be coupled to NAADP
signalling. The aforementioned work also reported that in cultures
of hippocampal glial cells, baﬁlomycin A1 did not reduce the mag-
nitude of ATP-induced Ca2+ responses, [12] in contrast to our data
showing a clear effect of baﬁlomycin A1 in ATP-induced Ca2+ re-
sponses in cortical astrocytes. All together, these results may
underline regional diversity within the glial lineage in respect to
the nature of Ca2+ lysosomal-like stores and agonist recruitment
of second messengers. Indeed, there is emerging data suggesting
that astrocytes are not a homogenous cell population, and that un-
ique characteristics of astrocytes of different regions may distinctly
tune the neuronal activities [23]. However, one cannot exclude
that discrepancies between our data and those reported in hippo-
campal astrocytes could be best explained by differences in the
methodology used. Whereas the experiments here were performed
in physiological-like conditions, Pandley and coworkers kept cells
in Ca2+-free medium. In such conditions lysosome-related Ca2+
homeostasis might also be altered.
Our results uncovering new intracellular signalling pathways
linked to activation of purinergic receptors in astrocytes are of
notable signiﬁcance as ATP not only acts a main astrocyte-to-astro-
cyte messenger, but also as a unique neuron-to-glia mediator [2].
Moreover, NAADP signalling pathway involvement in selective
neurotransmitter-induced responses demonstrates the complexity
of astrocytic Ca2+ signalling and hence excitability. Importantly, fu-
ture investigations in situ and in vivo based on our description of
astrocytic NAADP signalling coupled to ATP signalling could shed
light on the present debate on the role of astrocytes in synaptic
transmission in vivo [24].
In summary, we report that NAADP is an authentic intracellular
second messenger in cultured astrocytes and plays an important
role in ATP-mediated Ca2+ signals.
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